SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Galmed Pharmaceuticals Ltd. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | CVI Investments, Inc. | Galmed Pharmaceuticals Ltd. | 414,827 | 9.9% | EDGAR |
SC 13G/A | 2024-02-12 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 227,790 | 4.5% | EDGAR |
SC 13G | 2023-07-21 | CVI Investments, Inc. | Galmed Pharmaceuticals Ltd. | 207,573 | 9.9% | EDGAR |
SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Galmed Pharmaceuticals Ltd. | 923,424 | 3.7% | EDGAR |
SC 13G/A | 2023-02-07 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 3,416,822 | 13.6% | EDGAR |
SC 13G/A | 2022-02-14 | Nantahala Capital Management, LLC | Galmed Pharmaceuticals Ltd. | 297,947 | 1.2% | EDGAR |
SC 13G/A | 2022-02-11 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 3,416,822 | 13.6% | EDGAR |
SC 13G/A | 2022-01-27 | Ibex Investors LLC | Galmed Pharmaceuticals Ltd. | 355,560 | 1.4% | EDGAR |
SC 13G | 2021-02-16 | Nantahala Capital Management, LLC | Galmed Pharmaceuticals Ltd. | 1,926,899 | 9.0% | EDGAR |
SC 13G/A | 2021-02-12 | BIOTECHNOLOGY VALUE FUND L P | Galmed Pharmaceuticals Ltd. | 923,424 | 4.3% | EDGAR |
SC 13G/A | 2021-02-12 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 3,416,822 | 16.0% | EDGAR |
SC 13G/A | 2021-01-15 | Ibex Investors LLC | Galmed Pharmaceuticals Ltd. | 1,525,000 | 7.2% | EDGAR |
SC 13G | 2020-07-28 | Ibex Investors LLC | Galmed Pharmaceuticals Ltd. | 1,056,848 | 5.0% | EDGAR |
SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Galmed Pharmaceuticals Ltd. | 923,424 | 4.4% | EDGAR |
SC 13G/A | 2020-02-13 | 683 Capital Management, LLC | Galmed Pharmaceuticals Ltd. | 800,000 | 3.8% | EDGAR |
SC 13G/A | 2020-02-13 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 3,416,822 | 16.2% | EDGAR |
SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | Galmed Pharmaceuticals Ltd. | 923,424 | 4.4% | EDGAR |
SC 13G/A | 2019-02-14 | Hurvitz Chaim | Galmed Pharmaceuticals Ltd. | 778,965 | 3.7% | EDGAR |
SC 13G/A | 2019-02-11 | Baharaff Allen | Galmed Pharmaceuticals Ltd. | 3,416,822 | 16.3% | EDGAR |